Search filters

List of works by Dave Inman

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

scientific article published on 04 November 2020

Paulina is supported by:

About Paulina

Help